Rockwell Medical, Inc. Forecast, price target & analysts
Rockwell Medical, Inc. Target price 2025 - Analyst rating & recommendation
Rockwell Medical, Inc. Classifications & Recommendation:
Rockwell Medical, Inc. Price Target
| Target Price | $6.00 |
| Price | $1.63 |
| Potential |
268.10%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target Rockwell Medical, Inc. 2026 .
The average Rockwell Medical, Inc. target price is $6.00.
This is
268.10%
register free of charge
$7.00
329.45%
register free of charge
$5.00
206.75%
register free of charge
|
|
| A rating was issued by 3 analysts: 3 Analysts recommend Rockwell Medical, Inc. to buy, 0 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Rockwell Medical, Inc. stock has an average upside potential 2026 of
268.10%
register free of charge
|
Sales and Margin forecast 2024, 2025 to 2028
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Revenue Million $ | 83.61 | 100.32 |
| 14.83% | 19.98% | |
| EBITDA Margin | -6.26% | 4.97% |
| 67.90% | 179.45% | |
| Net Margin | -13.92% | 0.32% |
| 83.41% | 102.30% |
3 Analysts have issued a sales forecast Rockwell Medical, Inc. 2024 . The average Rockwell Medical, Inc. sales estimate is
This results in the following potential growth metrics:
2 Analysts have issued an Rockwell Medical, Inc. EBITDA forecast 2024. The average Rockwell Medical, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
3 Rockwell Medical, Inc. Analysts have issued a net profit forecast 2024. The average Rockwell Medical, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.36 | 0.01 |
| 80.95% | 102.78% | |
| P/E | 163.00 | |
| EV/Sales | 0.48 |
3 Analysts have issued a Rockwell Medical, Inc. forecast for earnings per share. The average Rockwell Medical, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Rockwell Medical, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Rockwell Medical, Inc....
Current Rockwell Medical, Inc. Upgrades & Downgrades Beta
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. | Locked ➜ Locked | Locked | Dec 23 2024 |
| HC Wainwright & Co. | Locked ➜ Locked | Locked | Nov 25 2024 |
| Rodman & Renshaw | Locked ➜ Locked | Locked | Nov 14 2024 |
| HC Wainwright & Co. | Locked ➜ Locked | Locked | Sep 11 2024 |
| HC Wainwright & Co. | Locked ➜ Locked | Locked | Sep 04 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.: Locked ➜ Locked
|
Dec 23 2024 |
|
Locked
HC Wainwright & Co.: Locked ➜ Locked
|
Nov 25 2024 |
|
Locked
Rodman & Renshaw: Locked ➜ Locked
|
Nov 14 2024 |
|
Locked
HC Wainwright & Co.: Locked ➜ Locked
|
Sep 11 2024 |
|
Locked
HC Wainwright & Co.: Locked ➜ Locked
|
Sep 04 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
